Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HHA1
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006399 | tRNA metabolic process | 7 | 1 |
GO:0006400 | tRNA modification | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008033 | tRNA processing | 8 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups | 3 | 1 |
GO:0052381 | tRNA dimethylallyltransferase activity | 4 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.338 |
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.489 |
CLV_NRD_NRD_1 | 210 | 212 | PF00675 | 0.445 |
CLV_NRD_NRD_1 | 80 | 82 | PF00675 | 0.302 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.328 |
CLV_PCSK_KEX2_1 | 183 | 185 | PF00082 | 0.299 |
CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.506 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.420 |
CLV_PCSK_KEX2_1 | 210 | 212 | PF00082 | 0.446 |
CLV_PCSK_KEX2_1 | 80 | 82 | PF00082 | 0.302 |
CLV_PCSK_PC1ET2_1 | 183 | 185 | PF00082 | 0.293 |
CLV_PCSK_PC1ET2_1 | 2 | 4 | PF00082 | 0.222 |
CLV_PCSK_PC1ET2_1 | 210 | 212 | PF00082 | 0.558 |
CLV_PCSK_PC7_1 | 186 | 192 | PF00082 | 0.488 |
CLV_PCSK_PC7_1 | 76 | 82 | PF00082 | 0.222 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.473 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.209 |
CLV_PCSK_SKI1_1 | 3 | 7 | PF00082 | 0.454 |
DEG_APCC_DBOX_1 | 185 | 193 | PF00400 | 0.434 |
DEG_APCC_DBOX_1 | 19 | 27 | PF00400 | 0.290 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.223 |
DOC_CYCLIN_RxL_1 | 88 | 101 | PF00134 | 0.483 |
DOC_CYCLIN_yCln2_LP_2 | 141 | 147 | PF00134 | 0.442 |
DOC_MAPK_gen_1 | 12 | 18 | PF00069 | 0.364 |
DOC_PP2B_LxvP_1 | 206 | 209 | PF13499 | 0.480 |
DOC_PP4_FxxP_1 | 204 | 207 | PF00568 | 0.404 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.302 |
DOC_USP7_UBL2_3 | 32 | 36 | PF12436 | 0.454 |
DOC_WW_Pin1_4 | 98 | 103 | PF00397 | 0.350 |
LIG_14-3-3_CanoR_1 | 39 | 43 | PF00244 | 0.316 |
LIG_Actin_WH2_2 | 118 | 136 | PF00022 | 0.389 |
LIG_Actin_WH2_2 | 19 | 34 | PF00022 | 0.338 |
LIG_BRCT_BRCA1_1 | 51 | 55 | PF00533 | 0.364 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.486 |
LIG_FHA_2 | 62 | 68 | PF00498 | 0.328 |
LIG_LIR_Gen_1 | 108 | 115 | PF02991 | 0.490 |
LIG_LIR_Gen_1 | 4 | 14 | PF02991 | 0.222 |
LIG_LIR_Gen_1 | 50 | 55 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 108 | 113 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 4 | 10 | PF02991 | 0.222 |
LIG_LIR_Nem_3 | 50 | 54 | PF02991 | 0.302 |
LIG_MLH1_MIPbox_1 | 51 | 55 | PF16413 | 0.364 |
LIG_NRBOX | 128 | 134 | PF00104 | 0.535 |
LIG_PCNA_yPIPBox_3 | 126 | 139 | PF02747 | 0.415 |
LIG_Pex14_2 | 110 | 114 | PF04695 | 0.540 |
LIG_Pex14_2 | 51 | 55 | PF04695 | 0.302 |
LIG_Rb_LxCxE_1 | 41 | 64 | PF01857 | 0.302 |
LIG_SH2_CRK | 7 | 11 | PF00017 | 0.222 |
LIG_SH2_STAT3 | 82 | 85 | PF00017 | 0.302 |
LIG_SH3_2 | 144 | 149 | PF14604 | 0.423 |
LIG_SH3_3 | 141 | 147 | PF00018 | 0.485 |
LIG_SUMO_SIM_par_1 | 56 | 67 | PF11976 | 0.222 |
LIG_TRFH_1 | 204 | 208 | PF08558 | 0.410 |
LIG_TYR_ITIM | 5 | 10 | PF00017 | 0.222 |
LIG_UBA3_1 | 145 | 149 | PF00899 | 0.564 |
LIG_WRC_WIRS_1 | 6 | 11 | PF05994 | 0.261 |
MOD_CDC14_SPxK_1 | 101 | 104 | PF00782 | 0.369 |
MOD_CDK_SPxK_1 | 98 | 104 | PF00069 | 0.354 |
MOD_CK2_1 | 194 | 200 | PF00069 | 0.493 |
MOD_CK2_1 | 38 | 44 | PF00069 | 0.276 |
MOD_CK2_1 | 63 | 69 | PF00069 | 0.326 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.622 |
MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.261 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.508 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.370 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.348 |
MOD_NEK2_1 | 54 | 59 | PF00069 | 0.258 |
MOD_NEK2_1 | 61 | 66 | PF00069 | 0.236 |
MOD_NEK2_1 | 97 | 102 | PF00069 | 0.465 |
MOD_PIKK_1 | 156 | 162 | PF00454 | 0.500 |
MOD_PIKK_1 | 49 | 55 | PF00454 | 0.364 |
MOD_PKA_2 | 133 | 139 | PF00069 | 0.442 |
MOD_PKA_2 | 185 | 191 | PF00069 | 0.493 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.308 |
MOD_Plk_1 | 49 | 55 | PF00069 | 0.370 |
MOD_Plk_4 | 5 | 11 | PF00069 | 0.279 |
MOD_ProDKin_1 | 98 | 104 | PF00069 | 0.354 |
MOD_SUMO_rev_2 | 24 | 29 | PF00179 | 0.222 |
TRG_DiLeu_BaLyEn_6 | 57 | 62 | PF01217 | 0.222 |
TRG_DiLeu_BaLyEn_6 | 90 | 95 | PF01217 | 0.307 |
TRG_ENDOCYTIC_2 | 7 | 10 | PF00928 | 0.222 |
TRG_ER_diArg_1 | 12 | 14 | PF00400 | 0.332 |
TRG_ER_diArg_1 | 189 | 191 | PF00400 | 0.490 |
TRG_ER_diArg_1 | 80 | 82 | PF00400 | 0.347 |
TRG_ER_diLys_1 | 210 | 215 | PF00400 | 0.638 |
TRG_NLS_MonoCore_2 | 209 | 214 | PF00514 | 0.558 |
TRG_NLS_MonoExtN_4 | 181 | 187 | PF00514 | 0.471 |
TRG_NLS_MonoExtN_4 | 207 | 214 | PF00514 | 0.590 |
TRG_Pf-PMV_PEXEL_1 | 139 | 143 | PF00026 | 0.460 |
TRG_Pf-PMV_PEXEL_1 | 190 | 195 | PF00026 | 0.448 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDI4 | Leptomonas seymouri | 54% | 100% |
A0A3Q8IIN6 | Leishmania donovani | 80% | 100% |
A4I4E7 | Leishmania infantum | 80% | 100% |
E9ADU7 | Leishmania major | 82% | 100% |
E9ALY3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |